Plasma KL-6 predicts the development and outcome of bronchopulmonary dysplasia

Pediatric Research

Volumn 60, Issue 5, 2006, Pages 613-618

  Ogihara, Tohru ^a   Hirano, Kazuya ^a   Morinobu, Takao ^a   Kim, Han Suk ^b   Ogawa, Satoru ^a   Hiroi, Mayo ^a   Oue, Shinya ^a   Ban, Ryoichi ^a   Hira, Seigo ^a   Hasegawa, Masashi ^a   Yamaoka, Shigeo ^a   Yasui, Masako ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; PROTEIN KL 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FIBROSIS; HUMAN; INFANT; INFLAMMATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOGRAPHY;

ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MUCINS; PREDICTIVE VALUE OF TESTS; PREGNANCY; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 33750299464     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000242361.47408.51     Document Type: Article

References (40)

1. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen TN 1987 Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:26-30
2. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM 1988 Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82:527-532
3. Jobe AH, Bancalari E 2001 Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729
4. Bancalari E, Abdenour GE, Feller R, Gannon J 1979 Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95:819-823
5. Ogawa Y, Fujimura M, Goto A, Kawano T, Kondo T, Nakae N, Nishida A, Ohno T, Takeuchi Y, Togari H, Maeta H, Oguchi K 1992 Epidemiology of neonatal chronic lung disease in Japan. Acta Paediatr Jpn 34:663-667
6. Bancalari E, Claure N, Sosenko IR 2003 Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8:63-71
7. Kohno N 1999 Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 46:151-158
8. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M 1988 Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18:203-216
9. Kohno N, Yokoyama A, Hirasawa Y, Kondo K, Fujino S, Abe M, Hiwada K 1997 Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Respir Med 91:558-561
10. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S 2004 Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 286:L1088-L1094
11. Al-Salmi QA, Walter JN, Colasurdo GN, Sockrider MM, Smith EO, Takahashi H, Fan LL 2005 Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. Chest 127:403-407
12. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N 2002 Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 165:378-381
13. Crouch E 1990 Pathobiology of pulmonary fibrosis. Am J Physiol 259:L159-L184
14. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K 1993 KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148:637-642
15. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K 1998 Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158:1680-1684
16. Sun AP, Ohtsuki Y, Fujita J, Ishida T, Yoshinouchi T, Kohno N 2003 KL-6, a human MUC1 mucin, is expressed early in premature lung. Respir Med 97:964-969
17. Ogihara T, Hirano K, Morinobu T, Ogawa S, Hiroi M, Ban R, Ogihara H, Tamai H 2000 KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn. J Pediatr 137:280-282
18. Watterberg KL, Demers LM, Scott SM, Murphy S 1996 Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 97:210-215
19. Jobe AH, Ikegami M 2001 Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res 2:27-32
20. Fujimura M, Takeuchi T, Ando M, Funato M, Shimada S, Tsujimoto A, Kanaya S, Kozuki K, Morimoto SK 1983 Elevated immunoglobulin M levels in low birthweight neonates with chronic respiratory insufficiency. Early Hum Dev 9:27-32
21. Speer CP 2003 Inflammation and bronchopulmonary dysplasia. Semin Neonatol 8:29-38
22. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK 1999 A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 181:773-779
23. An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, Sugai T, Kobayashi Y, Mori M, Seki K, Yokota S 2004 Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 191:1649-1654
24. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R 1991 New Ballard Score, expanded to include extremely premature infants. J Pediatr 119:417-423
25. Hodgman JE, Mikity VG, Tatter D, Cleland RS 1969 Chronic respiratory distress in the premature infant. Wilson-Mikity syndrome. Pediatrics 44:179-195
26. Blanc WA 1959 Amniotic infection syndrome: pathogenesis, morphology and significance in circumnatal mortality. Clin Obstet Gynecol 2:705-734
27. Ogihara T, Okamoto R, Kim HS, Nagai A, Morinobu T, Moji H, Kamegai H, Hirano K, Ogihara H, Tamai H, Mino M 1996 New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 39:117-119
28. Schmidt B, Cao L, Mackensen-Haen S, Kendziorra H, Klingel K, Speer CP 2001 Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 185:173-177
29. Ogihara T, Hirano K, Morinobu T, Kim HS, Hiroi M, Ogihara H, Tamai H 1999 Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease. Arch Dis Child Fetal Neonatal Ed 80:F21-F25
30. Saugstad OD 2001 Chronic lung disease: oxygen dogma revisited. Acta Paediatr 90:113-115
31. Wilson MG, Mikity VG 1960 A new form of respiratory disease in premature infants. Am J Dis Child 99:489-499
32. Swyer PR, Delivoria-Papadopoulos M, Levison H, Reilly BJ, Balis JU 1965 The pulmonary syndrome of Wilson and Mikity. Pediatrics 36:374-384
33. Wung JT, Koons AH, Driscoll JM Jr, James LS 1979 Changing incidence of bronchopulmonary dysplasia. J Pediatr 95:845-847
34. Charafeddine L, D'Angio CT, Phelps DL 1999 Atypical chronic lung disease patterns in neonates. Pediatrics 103:759-765
35. Jobe AJ 1999 The new BPD: an arrest of lung development. Pediatr Res 46:641-643
36. Hodgman JE 2003 Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia. Pediatrics 112:1414-1415
37. Fujimura M, Kitajima H, Nakayama M 1993 Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics 92:564-569
38. Takami T, Kumada A, Takei Y, Miyajima T, Hoshika A 2003 A case of Wilson-Mikity syndrome with high serum KL-6 levels. J Perinatol 23:56-58
39. Theilen U, Lyon AJ, Fitzgerald T, Hendry GM, Keeling JW 2004 Infection with Ureaplasma urealyticum: is there a specific clinical and radiological course in the preterm infant? Arch Dis Child Fetal Neonatal Ed 89:F163-F167
40. Yamane M, Yokoyama N 2004 Serum KL-6 level and pulmonary function in preterm infants with chronic lung disease. Kobe J Med Sci 50:131-140